Inconsistent reporting of surrogate outcomes in randomised clinical trials: Cohort study

BMJ (Online)

Volumn 341, Issue 7769, 2010, Pages 380-

  La Cour, Jeppe Lerche ^a,c   Brok, Jesper ^a,b   Gøtzsche, Peter C ^c  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; HUMAN; MEDICAL LITERATURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLICATION; VALIDITY;

COHORT STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 77956124790     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3653     Document Type: Article

References (20)

1. Bucher HC, Guyatt GH, Cook DJ, Holbrook A. Users' guides to the medical literature XIX. Applying clinical trial results. A. How to use an article measuring the effect of an intervention on surrogate end points. JAMA 1999;282:771-8.
2. Gluud C, Krogsgaard K. Would you trust a surrogate respondent? Lancet 1997;349:665-6.
3. Gøtzsche PC, Torri ALV, Rossetti L. Beware of surrogate outcome measures. Int J Technol Assess Health Care 1996;12:238-46.
4. Theodore Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D'Agostino RB, et al. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA 2006;296:2572-81.
5. Wier CJ, Walley RJ. Statistical evaluation of biomarkers as surrogate endpoints: a literature review. Stat Med 2006;25:183-203.
6. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusion in randomised drug trials - a reflection of treatment effect or adverse events? JAMA 2003;290:921-8.
7. Burns KEA, Chu MWA, Novick RJ, Fox SA, Gallo K, Martin CM, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 2005;294:342-50. (Pubitemid 41043778)
8. Lawrence J, Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, et al. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids results of the OmniHeart randomized trial. JAMA 2005;294:2455-64. (Pubitemid 41627923)
9. Mazzone T, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA 2006;295:2262-9.
10. Nissen SE, Tuzcu EM, Brewer HB, Sipahi I, Nicholls SJ, Ganz P, et al. Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl JMed 2006;354:1253-63.
11. Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 2006;332:1485-90.
12. Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91.
13. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-94. (Pubitemid 32322245)
14. Crotty M, Whitehead CH, Wundke R, Giles LC, Ben-Tovim D, Phillips PA. Transitional care facility for elderly people in hospital awaiting a long term care bed: randomised controlled trial. BMJ 2005;331:1110. (Pubitemid 41634894)
15. Cuzick J, Cafferty FH, Edwards R, Møller H, Duffy SW. Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening Trial. J Med Screen 2007;14:178-85. (Pubitemid 350223781)
16. Høj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial. BMJ 2005;331:723-8.
17. Baker SG, Kramer BS. A perfect correlate does not a surrogate make. BMC Med Res Methodol 2003;3:16.
18. Gluud C, Brok J, Gong Y, Koretz RL. Hepatology may have problems with putative surrogate outcome measures. J Hepatol 2007;46:734-42. (Pubitemid 46420383)
19. Rosen CJ. The rosiglitazone story - lessons from an FDA advisory committee meeting. N Engl J Med 2007;357:844-6.
20. Food and Drug Administration. Drug approvals and databases. 2008. www.fda.gov/cder/rdmt/accappr1.htm.